Published in Neurology on July 25, 2006
Ataxia telangiectasia: a review. Orphanet J Rare Dis (2016) 0.88
Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours. Br J Cancer (2011) 0.87
Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia. Br J Cancer (2011) 0.87
New mutations in the ATM gene and clinical data of 25 AT patients. Neurogenetics (2011) 0.85
Ataxia telangiectasia mutated impacts insulin-like growth factor 1 signalling in skeletal muscle. Exp Physiol (2012) 0.85
Clinical variability in ataxia-telangiectasia. J Neurol (2015) 0.85
Atypical presentation of late-onset Tay-Sachs disease. Muscle Nerve (2014) 0.78
Target-selected gene inactivation in Caenorhabditis elegans by using a frozen transposon insertion mutant bank. Proc Natl Acad Sci U S A (1993) 3.43
POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J Med Genet (2005) 2.80
Clinical spectrum of ataxia-telangiectasia in adulthood. Neurology (2009) 2.05
Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity. Cell (1993) 2.04
Clinical features of facioscapulohumeral muscular dystrophy 2. Neurology (2010) 2.01
Phenotype of Charcot-Marie-Tooth disease Type 2. Neurology (2007) 1.79
Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology (2008) 1.70
Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology (2000) 1.63
Polyneuropathy in lithium intoxication. Muscle Nerve (1990) 1.55
Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis (2006) 1.54
Ptosis as a feature of late-onset glycogenosis type II. Neurology (2006) 1.49
Antihypertensive treatment during pregnancy and functional development at primary school age in a historical cohort study. BJOG (2010) 1.48
Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. J Neurol Neurosurg Psychiatry (2005) 1.45
Quantitative ultrasonography of skeletal muscles in children: normal values. Muscle Nerve (2003) 1.44
Development and developmental disorders of the human cerebellum. J Neurol (2003) 1.44
Ileus in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes. Neth J Med (1998) 1.42
Quantitative skeletal muscle ultrasound: diagnostic value in childhood neuromuscular disease. Neuromuscul Disord (2007) 1.40
[Amyoplasia congenita: a serious congenital abnormality with a relatively favorable prognosis]. Ned Tijdschr Geneeskd (2002) 1.39
Pathological findings in a patient with amyotrophic lateral sclerosis and multifocal motor neuropathy with conduction block. J Neurol Sci (1996) 1.39
Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis. J Inherit Metab Dis (2002) 1.37
Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations. Neurology (2006) 1.30
Redefining the clinical phenotypes of non-dystrophic myotonic syndromes. J Neurol Neurosurg Psychiatry (2009) 1.29
In vitro action of bombesin and bombesin-like peptides on amylase secretion, calcium efflux, and adenylate cyclase activity in the rat pancreas: a comparison with other secretagogues. J Clin Invest (1976) 1.25
Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry (2004) 1.21
Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet (2007) 1.20
Sporadic late-onset nemaline myopathy effectively treated by melphalan and stem cell transplant. Neurology (2008) 1.20
ATM mutations in sporadic lymphoid tumours. Leuk Lymphoma (2002) 1.18
Clinical neurophysiology of fatigue. Clin Neurophysiol (2007) 1.17
Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients. Brain Res Bull (2003) 1.17
Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype. J Biol Chem (2001) 1.16
Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology (2001) 1.15
Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen. Ann Rheum Dis (2006) 1.12
Muscle cramp: main theories as to aetiology. Eur Arch Psychiatry Neurol Sci (1990) 1.12
99th ENMC international workshop: myotonic dystrophy: present management, future therapy. 9-11 November 2001, Naarden, The Netherlands. Neuromuscul Disord (2002) 1.12
Drug treatment for myotonia. Cochrane Database Syst Rev (2006) 1.11
Globoid cell leukodystrophy: a family with both late-infantile and adult type. Neurology (1991) 1.10
Treatment and follow-up of children with cerebrotendinous xanthomatosis. Eur J Pediatr (1998) 1.10
Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis. Ann Neurol (2000) 1.09
Quantitative skeletal muscle ultrasonography in children with suspected neuromuscular disease. Muscle Nerve (2003) 1.09
hMRE11: genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decay. Hum Mol Genet (2001) 1.08
Experienced and physiological fatigue in neuromuscular disorders. Clin Neurophysiol (2006) 1.08
Evaluation of prednisolone treatment in the acute phase of neuralgic amyotrophy: an observational study. J Neurol Neurosurg Psychiatry (2009) 1.06
Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis. Neuromuscul Disord (2013) 1.05
Strong association between myotonic dystrophy type 2 and autoimmune diseases. J Neurol Neurosurg Psychiatry (2009) 1.04
Peripheral primitive neuroectodermal tumour of the cervix. Virchows Arch (2000) 1.04
Simvastatin and plasma very-long-chain fatty acids in X-linked adrenoleukodystrophy. Ann Neurol (2000) 1.04
Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up. Eur Neurol (2004) 1.03
Aicardi-Goutières syndrome displays genetic heterogeneity with one locus (AGS1) on chromosome 3p21. Am J Hum Genet (2000) 1.03
The lethal phenotype of a homozygous nonsense mutation in the lamin A/C gene. Neurology (2005) 1.01
Hemorrhagic colloid cyst: case report and review of the literature. Surg Neurol (2006) 1.00
Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene. Clin Exp Immunol (2008) 1.00
Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy. J Neurol (2007) 0.99
Thickening of dura surrounding meningiomas: MR features. J Comput Assist Tomogr (1989) 0.99
Relation between muscle fiber conduction velocity and fiber size in neuromuscular disorders. J Appl Physiol (1985) (2006) 0.98
Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology (2004) 0.98
Development and malformations of the human pyramidal tract. J Neurol (2004) 0.98
Motor unit potential contribution to surface electromyography. Acta Physiol Scand (1997) 0.97
Detection of Toxoplasma gondii tachyzoites and bradyzoites in blood, urine, and brains of infected mice. Clin Diagn Lab Immunol (1996) 0.96
Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations. Eur Neurol (2003) 0.96
Hereditary neuropathy with liability to pressure palsies: a clinical, electroneurophysiological and morphological study. J Neurol Sci (1993) 0.96
Health status in non-dystrophic myotonias: close relation with pain and fatigue. J Neurol (2009) 0.96
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. Br J Cancer (2014) 0.96
Autosomal dominant transmission of GLUT1 deficiency. Hum Mol Genet (2001) 0.96
Cerebrotendinous xanthomatosis. Controversies about nerve and muscle: observations in ten patients. Neuromuscul Disord (2000) 0.95
Cutaneous granulomas in ataxia telangiectasia and other primary immunodeficiencies: reflection of inappropriate immune regulation? Dermatology (2011) 0.95
Clinical and genetic heterogeneity in autosomal recessive nemaline myopathy. Neuromuscul Disord (1999) 0.95
A locus on chromosome 15q for a dominantly inherited nemaline myopathy with core-like lesions. Brain (2003) 0.95
Creatine kinase (CK) in skeletal muscle energy metabolism: a study of mouse mutants with graded reduction in muscle CK expression. Proc Natl Acad Sci U S A (1994) 0.95
The motor unit potential distribution over the skin surface and its use in estimating the motor unit location. Acta Physiol Scand (1997) 0.95
Muscle ultrasound measurements and functional muscle parameters in non-dystrophic myotonias suggest structural muscle changes. Neuromuscul Disord (2009) 0.94
Calcium regulation and muscle disease. J Muscle Res Cell Motil (2002) 0.94
The neuropathology of hereditary congenital facial palsy vs Möbius syndrome. Neurology (2005) 0.94
Sensorineural hearing impairment in patients with Pmp22 duplication, deletion, and frameshift mutations. Otol Neurotol (2005) 0.94
Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTX. J Inherit Metab Dis (2008) 0.93
Diminished central activation during maximal voluntary contraction in chronic fatigue syndrome. Clin Neurophysiol (2004) 0.92
Ethanol-induced disturbances of gliogenesis and neuronogenesis in the developing murine brain: an in vitro and in vivo immunohistochemical and ultrastructural study. Alcohol Alcohol (1992) 0.92
Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis. Neurology (2004) 0.92
MECP2 mutation in a boy with severe neonatal encephalopathy: clinical, neuropathological and molecular findings. Neuropediatrics (2002) 0.91
Open-label trial of anti-TNF-alpha in dermato- and polymyositis treated concomitantly with methotrexate. Eur Neurol (2008) 0.91
Sensory nerve conduction studies in neuralgic amyotrophy. Am J Phys Med Rehabil (2009) 0.90
Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study. J Neurol (2012) 0.90
Paralysis of saccades and pursuit: clinicopathologic study. Neurology (1991) 0.90
Prominent dural enhancement adjacent to nonmeningiomatous malignant lesions on contrast-enhanced MR images. AJNR Am J Neuroradiol (1991) 0.89
Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism. NMR Biomed (2010) 0.89
Skeletal muscle of mice with a mutation in slow alpha-tropomyosin is weaker at lower lengths. Neuromuscul Disord (2002) 0.89
High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disorders. J Neurol (2005) 0.89
Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP. Neurology (2005) 0.89
The expression of two P-glycoprotein (pgp) genes in transgenic Caenorhabditis elegans is confined to intestinal cells. EMBO J (1993) 0.89
A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling. Arch Dis Child (2003) 0.89
Pulmonary lymphangioleiomyomatosis and cerebrotendinous xanthomatosis: is there a link? Chest (1997) 0.88
The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands. Neurology (2004) 0.88
Clinical and molecular genetic features of congenital spinal muscular atrophy. Ann Neurol (1996) 0.88
Persistent periodic hiccups following brain abscess: a case report. J Neurol Neurosurg Psychiatry (1990) 0.87
Statin-disclosed acid maltase deficiency. J Intern Med (2005) 0.87
MIDD or MELAS : that's not the question MIDD evolving into MELAS : a severe phenotype of the m.3243A>G mutation due to paternal co-inheritance of type 2 diabetes and a high heteroplasmy level. Neth J Med (2012) 0.87